EUVIMEDEUVIMED entdecken
Crossref

Individual alpha peak frequency tracks Alzheimer's disease progression: A longitudinal pilot study

Ruimin Wang iD, Takao Yamasaki, Takako Mitsudo, Yoshitaka Matsuda iD, Satoru Goto iD, Takenao Sugi

Journal of Alzheimer’s Disease · 2026

DOI: 10.1177/13872877261476331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2026. Verfasst von Ruimin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical and Electronic Engineering, Faculty of Science and Engineering, Saga University, Saga, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease, Disease Progression, Alpha Rhythm. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early and accurate tracking of Alzheimer's disease (AD) progression is critical for timely intervention. However, electrophysiological biomarkers capable of capturing long-term neurodegenerative changes remain largely underexplored.

Objective

We investigated whether individual alpha peak frequency (IAPF), an electroencephalography (EEG)-derived measure of dominant neural oscillatory activity, could serve as a longitudinal biomarker of AD progression.

Methods

Twenty-seven patients with AD aged 63–91 years underwent annual EEG and cognitive assessments over 2–7 years. IAPF was extracted from eyes-closed resting-state EEG. Longitudinal associations among IAPF, Mini-Mental State Examination (MMSE) scores, age, and follow-up time were evaluated using repeated-measures correlation and linear mixed-effects models. Annual IAPF changes were compared with those of healthy controls (HC) aged 20–70 years, stratified by decade-based age subgroups. Longitudinal changes in relative spectral power were also analyzed.

Results

Patients with AD showed significant longitudinal declines in both IAPF and MMSE scores, with a positive longitudinal association between the two measures. Mixed-effects models indicated that these declines were better explained by follow-up time after accounting for baseline age than by age at assessment alone. Compared with all healthy-control age subgroups, patients with AD exhibited a significantly steeper annual IAPF decline. Relative theta power increased and alpha/beta power decreased over follow-up, consistent with spectral slowing. However, annualized spectral-power changes showed limited disease specificity, with significant AD–HC differences only for delta and alpha power relative to the oldest HC subgroup.

Conclusions

These findings support IAPF as a non-invasive, temporally sensitive, and clinically accessible biomarker for monitoring AD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDisease ProgressionAlpha RhythmHumansFemalePilot ProjectsAgedMaleLongitudinal StudiesMiddle AgedAged, 80 and overElectroencephalographyNeuropsychological TestsMental Status and Dementia TestsAdult

Stichwörter der Autor:innen

Alzheimer's diseaseMini-Mental State Examinationbiomarkersdementiaelectroencephalographyindividual alpha peak frequencylong-term care utilization

Autor:innen und Institutionen

  • Department of Electrical and Electronic Engineering, Faculty of Science and Engineering, Saga University, Saga, Japan.
  • Department of Neurology, Minkodo Minohara Hospital, Fukuoka, Japan.
  • National Hospital Organization, Hizen Psychiatric Center, Saga, Japan.
  • Institute of Ocean Energy, Saga University, Saga, Japan.

ORCID-Profile: Ruimin Wang, Yoshitaka Matsuda, Satoru Goto

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Wang, R., Yamasaki, T., Mitsudo, T., Matsuda, Y., Goto, S., & Sugi, T. (2026). Individual alpha peak frequency tracks Alzheimer's disease progression: A longitudinal pilot study. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261476331

Vancouver

Wang R, Yamasaki T, Mitsudo T, Matsuda Y, Goto S, Sugi T. Individual alpha peak frequency tracks Alzheimer's disease progression: A longitudinal pilot study. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261476331

BibTeX
@article{Wang2026,
  author = {Wang, Ruimin and Yamasaki, Takao and Mitsudo, Takako and Matsuda, Yoshitaka and Goto, Satoru and Sugi, Takenao},
  title = {Individual alpha peak frequency tracks Alzheimer's disease progression: A longitudinal pilot study},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877261476331}
}
Kostenlos starten →